Because the expression of OLFM2 in adipose tissue mirrors its expression in the liver and increases as liver conditions worsen, and given the regulatory role that OLFM2 may play in lipid metabolism [14], we decided to evaluate the relative mRNA expression of OLFM2 in terms of the degree of steatosis in NAFLD patients. The gene discussed is OLFM2; the disease is steatosis.